Depressive Disorder  >>  bupropion sustained-release  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bupropion sustained-release / Generic mfg.
NCT00135512: Study Of 323U66 SR In Major Depressive Disorder

Completed
2
234
Japan, RoW
bupropion hydrochloride
GlaxoSmithKline
Depressive Disorder
05/07
05/07
NCT00330616: Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Completed
2
35
Japan
323U66 SR
GlaxoSmithKline
Major Depressive Disorder (MDD)
11/07
11/07

Download Options